Kera Capital Partners, Inc.
Position in CRL — Charles River Laboratories International, Inc.
CIK 2040353
SACRAMENTO, CA
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$459,476
+$84,979 QoQ
Shares Held
2,026
-6.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#314
of 564 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $8,451,773 across 12 Diagnostics & Research names. CRL ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
|
91,108 | $2,596,578 | |
| 2 | ILMN |
Illumina, Inc.
|
6,640 | $1,167,511 | |
| 3 | A |
Agilent Technologies, Inc.
|
7,191 | $955,180 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
3,772 | $728,825 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,026 | $459,476 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
859 | $454,917 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,999 | $423,688 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
292 | $373,032 |
All Filings in CRL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $459,476 | 2,026 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $374,497 | 2,171 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $500,894 | 2,511 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $375,973 | 2,403 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $280,700 | 1,850 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $285,988 | 1,900 | Shares | Sole | 2025-04-02 | |
| 2024-12-31 | $245,887 | 1,332 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||